Shareholder Information
Share management and Shareholder Meeting information
Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced
July 25 2024 Download (637KB)2024 Jefferies Global Healthcare Conference
June 5 2024 Download (905KB)Analyst Teach-in
May 23 2024 Download (4.82MB)Q1 2024 Financial Results
April 25 2024 Download (529KB)Annual Report and Accounts 2023
March 13 2024 Download (15.6MB)Indivior Announces Q2 2024 Financial Results
July 25 2024Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame
July 25 2024Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT
July 9 2024Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest
June 18 2024Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
June 10 2024